NSE · BAYERCROP
Bayer Cropscience Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1,101 Cr with net profit ₹162 Cr — a 14.73% net margin, versus 11.94% the period before.
Shareholding
As of 2026-06-30
- Promoter71.43%
- Public12.96%
- FII3.97%
- DII11.64%
58,884 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.62× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Pesticides / Agrochemicals - Multinational · ranked #1 of 1 by market cap
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Bayer Cropscience Ltd.(this company) | — | 117.78 | 6.43 | — | — |
AI analysis
AI-generated · google/gemini-2.5-flashBayer Cropscience Ltd., listed as BAYERCROP, has a market capitalization of Rs 19149 Cr. The company reported revenue of Rs 56750000000 and a net profit of Rs 6892000000 as of March 2026. Its price-to-earnings ratio is 27.79, with an EPS of 153.35. The dividend yield stands at 141.
Positives
- +The company has a high return on capital employed (ROCE) of 28.70%.
- +The return on equity (ROE) of 23.24% indicates efficient use of shareholder funds.
- +The debt-to-equity ratio is 0.37, indicating low leverage.
- +Promoter holding is high at 71.4319% as of June 30, 2026.
Negatives
- −The profit margin is 12.14%, which may be considered moderate depending on sector comparisons.
- −The promoter shareholding has decreased from 68.692% in September 2017 to 71.4319% in June 2026.
- −Annual revenue has fluctuated unevenly; the latest reported annual revenue in Mar 2026 is Rs 56750000000 compared to Rs 1100.8 Cr in a previous entry for Mar 2026 suggesting data inconsistencies or different reporting metrics.
Financial Performance
For the period ending March 2026, Bayer Cropscience Ltd. recorded revenue of Rs 56750000000 and a net profit of Rs 6892000000. Prior to this, in December 2025, the company had reported revenue of Rs 1106.2 Cr and a net profit of Rs 95.7 Cr. The EBITDA for the March 2026 period was Rs 0 Cr, compared to Rs 118.2 Cr in December 2025.
Profitability & Returns
Bayer Cropscience Ltd. has a profit margin of 12.14%. The company's return on equity (ROE) is 23.24%, and its return on capital employed (ROCE) is 28.7022. The EPS stands at 153.35, contributing to a PE ratio of 27.79.
Balance Sheet
The company maintains a book value of Rs 659.9. Its debt-to-equity ratio is 0.37, indicating its leverage. No specific details about the composition of debt or additional asset information are provided.
Ownership & Pledges
Public shareholding is 12.9644%. There are no promoter pledges reported for the latest period.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.